Kyle Rose
Stock Analyst at Canaccord Genuity
(3.28)
# 958
Out of 4,778 analysts
122
Total ratings
50.51%
Success rate
11.89%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $28.03 | -3.67% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $274.04 | +18.23% | 16 | Feb 21, 2025 | |
| FNA Paragon 28 | Downgrades: Hold | n/a | $13.00 | - | 8 | Jan 29, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $374.27 | +16.23% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $76.06 | -6.65% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $40.00 | +77.50% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $19.00 | +15.79% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.41 | +609.22% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.49 | +109.72% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $75.32 | +99.15% | 17 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $360 → $270 | $8.06 | +3,249.88% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $14.82 | +82.19% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.40 | +971.43% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $18.15 | -17.36% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $175.25 | -30.39% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $2.82 | +41.84% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.72 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $111.24 | +12.37% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $28.03
Upside: -3.67%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $274.04
Upside: +18.23%
Paragon 28
Jan 29, 2025
Downgrades: Hold
Price Target: n/a
Current: $13.00
Upside: -
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $374.27
Upside: +16.23%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $76.06
Upside: -6.65%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $40.00
Upside: +77.50%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $19.00
Upside: +15.79%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.49
Upside: +109.72%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $75.32
Upside: +99.15%
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $8.06
Upside: +3,249.88%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.82
Upside: +82.19%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.40
Upside: +971.43%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $18.15
Upside: -17.36%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $175.25
Upside: -30.39%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.82
Upside: +41.84%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $9.72
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $111.24
Upside: +12.37%